Announced 32 days laterFiled 13 February 2025
Latigo Biotherapeutics, Inc. raised $50M
Latigo Biotherapeutics, Inc., a biotech company based in Thousand Oaks, CA, raised $50M in a new equity round, according to a filing dated 13 February 2025.
Filed 32 days before it was announced on 17 March 2025. latigobio.com ↗
- Filed
- 13 February 2025
- Round
- Equity round
- Amount sold
- $50M
- Offering size
- $150M
- Investors so far
- 7
- Based in
- Thousand Oaks, CA
- Website
- latigobio.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 89% of the 1,404 tracked raises with an amount filed in 2025, and than 80% of the 112 in biotech.
Latigo Biotherapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 13 Feb 2025 | New filing | $50M | This raise |
More with Westlake BioPartners on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.